查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1696292

全球医用气体市场 - 2025 - 2033

Global Medical Gas Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球医用气体市场规模达 189.8 亿美元，预计到 2033 年将达到 683.1 亿美元，2025-2033 年预测期内的复合年增长率为 13.6%。

医用气体是用于各种医疗应用（包括治疗、诊断和製药）的专业类别。其中包括氧气、一氧化二氮、二氧化碳、氦气、氮气和医用空气。氧气用于慢性阻塞性肺病和低氧血症等疾病的呼吸支持，而一氧化二氮则用于外科手术中的麻醉剂。二氧化碳对于微创手术中的充气至关重要，而氦气则用于呼吸治疗。

氮气在低温保存和医学研究中必不可少，而医用空气则用于呼吸机和病人护理环境。由于呼吸系统疾病、外科手术技术和家庭医疗保健产业的不断扩大，对医用气体的需求不断增加。由于气体输送系统和医疗保健基础设施的创新，预计全球市场将成长。

市场动态：

驱动因素与约束因素

呼吸系统疾病盛行率不断上升

纯医用气体市场的成长是由慢性阻塞性肺病、气喘和睡眠呼吸中止症等呼吸系统疾病的日益流行所推动的。由于老龄人口的增长、污染水平的提高、工业排放以及吸烟率的上升，对高纯度医用气体的需求也在增加。医疗设施、家庭护理服务的扩展以及气体输送系统的进步对于纯医用气体在呼吸治疗中的广泛应用至关重要。

例如，慢性呼吸道疾病（CRD），包括慢性阻塞性肺病、气喘、肺癌和职业性肺部疾病，是影响 5,500 亿成年人并占所有死亡人数的 7% 的全球重大健康问题。肺癌每年导致另外14亿人死亡。五岁以下儿童特别容易患肺部疾病，其中气喘是最常见的慢性病。儘管 1990 年至 2017 年间慢性疾病的发生率增加了 40%，但慢性疾病受到的关注却少于其他非传染性疾病。

因此，慢性呼吸系统疾病（CRD）的日益普及推动了对氧气治疗和吸入治疗等医用气体的需求，同时医疗保健投资和对 CRD 管理的认识也不断增加。

严格的监管要求

FDA、USP 和 ISO 等组织制定的关于纯医用气体的生产、储存和运输的严格规定对市场成长构成了重大挑战，可能会限制新参与者的进入并影响市场扩张。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

第三章：市场亮点与策略要点

  • 主要趋势和未来预测

第 4 章：依产品类型分类

  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 5 章：动态

  • 影响因素
    • 驱动程式
      • 呼吸系统疾病盛行率不断上升
      • 医用气体输送系统的技术进步
    • 限制
      • 严格的监管要求
      • 医用气体设备和基础设施成本高昂
    • 机会
      • 增加新兴市场的医疗保健投资
    • 影响分析

第六章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 7 章：按产品类型

  • 纯气体
  • 混合气体
  • 其他的

第 8 章：按应用

  • 呼吸治疗
  • 心血管治疗
  • 麻醉
  • 冷冻手术
  • 其他的

第 9 章：按最终用户

  • 医院和诊所
  • 门诊手术中心 (ASC)
  • 家庭医疗保健
  • 製药及生技公司

第 10 章：区域市场分析与成长机会

第 11 章：简介

  • 北美洲
    • 各区域关键动态
      • 我们
      • 加拿大
  • 欧洲
    • 各区域关键动态
      • 德国
      • 英国
      • 法国
      • 西班牙
      • 义大利
      • 欧洲其他地区
  • 拉丁美洲
    • 各区域关键动态
      • 墨西哥
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地区
  • 亚太
    • 各区域关键动态
      • 中国
      • 印度
      • 日本
      • 韩国
      • 亚太其他地区
  • 中东和非洲
    • 各区域关键动态

第 12 章：竞争格局与市场定位

第 13 章：竞争概况与主要市场参与者

  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 14 章：公司简介

  • Air Liquide
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量

第 15 章：财务概况

  • 公司收入
    • 地区收入份额
      • 收入预测
    • 关键进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • 林德公司
  • 空气产品和化学品有限公司
  • 梅塞尔集团有限公司
  • SOL集团
  • Matheson Tri-Gas 公司
  • 阿特拉斯·科普柯
  • GCE集团
  • 诺瓦燃气技术公司
  • Gruppo SIAD（非详尽名单）

第 16 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 17 章：附录

简介目录
Product Code: MD9412

The global medical gas market reached US$ 18.98 billion in 2024 and is expected to reach US$ 68.31 billion by 2033, growing at a CAGR of 13.6% during the forecast period 2025-2033.

Medical gas is a specialized category used in various medical applications, including therapeutic, diagnostic, and pharmaceutical. It includes oxygen, nitrous oxide, carbon dioxide, helium, nitrogen, and medical air. Oxygen is used for respiratory support in conditions like COPD and hypoxemia, while nitrous oxide is used as an anaesthetic in surgical procedures. Carbon dioxide is crucial for insufflation during minimally invasive surgeries, and helium is used in respiratory treatments.

Nitrogen is essential in cryopreservation and medical research, while medical air is used in ventilators and patient care environments. The demand for medical gases has increased due to respiratory diseases, surgical techniques, and the expanding home healthcare sector. The market is expected to grow globally due to innovations in gas delivery systems and healthcare infrastructure.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Respiratory Disorders

The growth of the pure medical gases market is driven by the increasing prevalence of respiratory diseases like COPD, asthma, and sleep apnea. The demand for high-purity medical gases is also increasing due to the growing elderly population, pollution levels, industrial emissions, and higher smoking rates. The expansion of healthcare facilities, home care services, and advancements in gas delivery systems are crucial for the widespread adoption of pure medical gases for respiratory treatments.

For instance, Chronic respiratory diseases (CRDs), including COPD, asthma, lung cancer, and occupational lung diseases, are significant global health issues affecting 550 billion adults and accounting for 7% of all deaths. Lung cancer contributes to another 1.4 billion deaths annually. Children under five are particularly affected by lung diseases, with asthma being the most common chronic condition. Despite a 40% increase in prevalence between 1990 and 2017, CRDs have received less attention than other NCDs.

Hence, the increasing prevalence of chronic respiratory diseases (CRDs) drives demand for medical gases like oxygen therapy and inhaled treatments, with increased healthcare investments and awareness in CRD management.

Stringent Regulatory Requirements

The strict regulations on the production, storage, and transportation of pure medical gases, set by organizations like the FDA, USP, and ISO, are posing a significant challenge to market growth, potentially limiting new player entry and affecting market expansion.

Segment Analysis

The global medical gas market is segmented based on product type, application, end-user, and region.

Product Type:

The pure gases from product type segment is expected to dominate the medical gas market with the highest market share

The pure gases from the product type segment are expected to dominate the medical gas market with the highest market share.

Pure gases, including oxygen, nitrogen, nitrous oxide, carbon dioxide, and helium, are high-purity, single-component gases used in therapeutic applications, anaesthesia, respiratory treatments, diagnostic imaging, and pharmaceutical manufacturing due to their unique physiological and chemical properties.

The demand for pure medical gases is increasing due to respiratory disorders like COPD and asthma, surgical procedures requiring anaesthesia gases, and biotechnology and pharmaceutical research applications.

Advancements in gas delivery systems, stringent regulatory standards, and the growing adoption of home healthcare services fuel market growth. For instance, in October 2023, Bausch + Lomb Corporation launched its Pure-line gas range in Europe, available in pure or premixed iterations of SF6, C2F6, and C3F8. This is the latest addition to the company's surgical retina portfolio, which includes intraocular dyes for posterior and anterior staining, as well as intraocular dyes for anterior staining.

Geographical Analysis

North America is expected to hold a significant position in the medical gas market with the highest market share

North America is expected to hold a significant position in the medical gas market with the highest market share. The North American medical gas market is fueled by rising respiratory diseases, geriatric populations, and surgical procedures requiring anaesthesia gases. Also, Regulatory support and stringent safety standards ensure the widespread adoption of medical gas systems in hospitals, ambulatory surgical centres, and research facilities.

Moreover, significant partnerships, advancements in healthcare infrastructure, and expanding home healthcare services contribute to market growth. For instance, in March 2025, Meritus Gas Partners partnered with Oxygen Service Company, a leading independent distributor of packaged gases and welding supplies based in Saint Paul, Minnesota. OSC, a 100% employee-owned company, offers a wide range of products and services, including industrial, specialty, and medical gases, automation equipment, and welding and safety supplies.

Competitive Landscape

The major global players in the medical gas market include Air Liquide, Linde plc, Air Products and Chemicals, Inc., Messer Group GmbH, SOL Group, Matheson Tri-Gas, Inc., Atlas Copco, GCE Group, Nova Gas Technologies, and Gruppo SIAD, among others.

Key Developments

  • In January 2025, INOX Air Products, India's largest industrial gases manufacturer, inaugurated the country's first ultra-high purity electronic grade nitrous oxide plant in Manali, Chennai, with a capacity of 1,700 tonnes per annum, ensuring high purity.
  • In July 2024, Adenia Partners acquired Air Liquide's operations in 12 African countries, forming Erium, the first pan-African leader in industrial and medical gases. Erium will replace Air Liquide in Benin, Burkina Faso, Cameroon, Congo, Cote d'Ivoire, Gabon, Ghana, Madagascar, Mali, the Democratic Republic of Congo, Senegal, and Togo.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical gas market report delivers a detailed analysis with 62 key tables, more than 55 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

3. Market Highlights and Strategic Takeaways

  • 3.1. Key Trends and Future Projections

4. Snippet by Product Type

  • 4.1. Snippet by Application
  • 4.2. Snippet by End-User
  • 4.3. Snippet by Region

5. Dynamics

  • 5.1. Impacting Factors
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Respiratory Disorders
      • 5.1.1.2. Technological Advancements in Medical Gas Delivery Systems
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent Regulatory Requirements
      • 5.1.2.2. High Cost of Medical Gas Equipment and Infrastructure
    • 5.1.3. Opportunity
      • 5.1.3.1. Increasing Healthcare Investments in Emerging Markets
    • 5.1.4. Impact Analysis

6. Strategic Insights and Industry Outlook

  • 6.1. Market Leaders and Pioneers
    • 6.1.1. Emerging Pioneers and Prominent Players
    • 6.1.2. Established leaders with largest selling Brand
    • 6.1.3. Market leaders with established Product
  • 6.2. CXO Perspectives
  • 6.3. Latest Developments and Breakthroughs
  • 6.4. Case Studies/Ongoing Research
  • 6.5. Regulatory and Reimbursement Landscape
    • 6.5.1. North America
    • 6.5.2. Europe
    • 6.5.3. Asia Pacific
    • 6.5.4. Latin America
    • 6.5.5. Middle East & Africa
  • 6.6. Porter's Five Force Analysis
  • 6.7. Supply Chain Analysis
  • 6.8. Patent Analysis
  • 6.9. SWOT Analysis
  • 6.10. Unmet Needs and Gaps
  • 6.11. Recommended Strategies for Market Entry and Expansion
  • 6.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 6.13. Pricing Analysis and Price Dynamics
  • 6.14. Key Opinion Leaders

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Pure Gases*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Gas Mixtures
  • 7.4. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Respiratory Therapy*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Cardiovascular Therapy
  • 8.4. Anesthesia
  • 8.5. Cryosurgery
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals & Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers (ASCs)
  • 9.4. Home Healthcare
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Regional Market Analysis and Growth Opportunities

11. Introduction

  • 11.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.1. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.6.1. U.S.
      • 11.2.6.2. Canada
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.6.1. Germany
      • 11.3.6.2. U.K.
      • 11.3.6.3. France
      • 11.3.6.4. Spain
      • 11.3.6.5. Italy
      • 11.3.6.6. Rest of Europe
  • 11.4. Latin America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.6.1. Mexico
      • 11.4.6.2. Brazil
      • 11.4.6.3. Argentina
      • 11.4.6.4. Rest of Latin America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.6.1. China
      • 11.5.6.2. India
      • 11.5.6.3. Japan
      • 11.5.6.4. South Korea
      • 11.5.6.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape and Market Positioning

13. Competitive Overview and Key Market Players

  • 13.1. Market Share Analysis and Positioning Matrix
  • 13.2. Strategic Partnerships, Mergers & Acquisitions
  • 13.3. Key Developments in Product Portfolios and Innovations
  • 13.4. Company Benchmarking

14. Company Profiles

  • 14.1. Air Liquide*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio
      • 14.1.2.1. Product Description
      • 14.1.2.2. Product Key Performance Indicators (KPIs)
      • 14.1.2.3. Historic and Forecasted Product Sales
      • 14.1.2.4. Product Sales Volume

15. Financial Overview

  • 15.1. Company Revenue's
    • 15.1.1. Geographical Revenue Shares
      • 15.1.1.1. Revenue Forecasts
    • 15.1.2. Key Developments
      • 15.1.2.1. Mergers & Acquisitions
      • 15.1.2.2. Key Product Development Activities
      • 15.1.2.3. Regulatory Approvals, etc.
    • 15.1.3. SWOT Analysis
  • 15.2. Linde plc
  • 15.3. Air Products and Chemicals, Inc.
  • 15.4. Messer Group GmbH
  • 15.5. SOL Group
  • 15.6. Matheson Tri-Gas, Inc.
  • 15.7. Atlas Copco
  • 15.8. GCE Group
  • 15.9. Nova Gas Technologies
  • 15.10. Gruppo SIAD (LIST NOT EXHAUSTIVE)

16. Assumption and Research Methodology

  • 16.1. Data Collection Methods
  • 16.2. Data Triangulation
  • 16.3. Forecasting Techniques
  • 16.4. Data Verification and Validation

17. Appendix

  • 17.1. About Us and Services
  • 17.2. Contact Us